Cargando…
Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3
Metastasis is the leading cause of mortality in breast cancer patients and lysophosphatidate (LPA) signaling promotes this process. LPA signaling is attenuated by lipid phosphate phosphatase-1 (LPP1) whose activity is decreased in cancers. Consequently, increasing LPP1 levels suppresses breast tumor...
Autores principales: | Tang, Xiaoyun, McMullen, Todd P.W., Brindley, David N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735510/ https://www.ncbi.nlm.nih.gov/pubmed/31534541 http://dx.doi.org/10.7150/thno.37094 |
Ejemplares similares
-
Lipid phosphate phosphatase-2 promotes tumor growth through increased c-Myc expression
por: Tang, Xiaoyun, et al.
Publicado: (2022) -
Lipid Phosphate Phosphatases and Cancer
por: Tang, Xiaoyun, et al.
Publicado: (2020) -
Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion
por: Benesch, Matthew G. K., et al.
Publicado: (2023) -
Lipid phosphate phosphatase-3 regulates tumor growth via β-catenin and Cyclin-D1 signaling
por: Chatterjee, Ishita, et al.
Publicado: (2011) -
Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo
por: Benesch, Matthew G.K., et al.
Publicado: (2016)